Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension

Completed · Phase 1

Conditions studied: Healthy, PK Drug-drug Interaction Study

In brief

This study has been designed to assess the safety, tolerability, and pharmacokinetics of a therapeutic dose of hydrocodone bitartrate with and without an oral dose of doxapram hydrochloride in healthy volunteers who are naltrexone-blocked.

Key facts

Study ID

NCT06585163

Run by

Quivive Pharma, Inc.

People needed

8

Starts

2025-08-18

Expected to finish

2025-11-26

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Frontage Clinical Services, Inc. — Secaucus, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.